AAAAAA
Results:
1-13
|
Results: 13
Authors:
NEIJT JP
ENGELHOLM SA
TUXEN M
SORENSEN PG
HANSEN M
SESSA C
DESWART CAM
HIRSCH FR
WITTEVEEN PO
LUND B
HANSEN SW
PALLE B
ROER O
VANHOUWELINGEN HC
Citation: Jp. Neijt et al., PACLITAXEL-CISPLATIN VS. PACLITAXEL-CARBOPLATIN IN PREVIOUSLY UNTREATED OVARIAN-CANCER, Annals of oncology, 9, 1998, pp. 312-312
Authors:
SENGELOV L
KAMBY C
LUND B
ENGELHOLM SA
Citation: L. Sengelov et al., DOCETAXEL AND CISPLATIN IN METASTATIC UROTHELIAL CANCER - A PHASE-II STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3392-3397
Authors:
SENGELOV L
KAMBY C
LUND B
ENGELHOLM SA
Citation: L. Sengelov et al., TAXOTERE AND CISPLATIN IN METASTATIC UROTHELIAL CANCER - A PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 119-119
Authors:
NEIJT JP
ENGELHOLM SA
WITTEVEEN PO
TUXEN MK
SORENSEN PG
HANSEN M
HIRSCH F
SESSA C
DESWART C
VANHOUWELINGEN HC
LUND B
HANSEN SW
Citation: Jp. Neijt et al., PACLITAXEL (175 MG M(2) OVER 3 HOURS) WITH CISPLATIN OR CARBOPLATIN IN PREVIOUSLY UNTREATED OVARIAN-CANCER - AN INTERIM ANALYSIS/, Seminars in oncology, 24(5), 1997, pp. 36-39
Authors:
POULSEN HK
JACOBSEN M
BERTELSEN K
ANDERSEN JE
AHRONS S
BOCK J
BOSTOFTE E
ENGELHOLM SA
HOLUND B
JAKOBSEN A
KIAER H
NYLAND M
PEDERSEN PH
STROYER I
Citation: Hk. Poulsen et al., ADJUVANT RADIATION-THERAPY IS NOT NECESSARY IN THE MANAGEMENT OF ENDOMETRIAL CARCINOMA STAGE-I, LOW-RISK CASES, International journal of gynecological cancer, 6(1), 1996, pp. 38-43
Authors:
BACH F
SORENSEN JB
ADRIAN L
LARSEN H
LANGER SW
NELAUSEN KM
ENGELHOLM SA
Citation: F. Bach et al., BRAIN RELAPSES IN CHEMOTHERAPY-TREATED SMALL-CELL LUNG-CANCER - A RETROSPECTIVE REVIEW OF 2 TIME-DOSE REGIMENS OF THERAPEUTIC BRAIN IRRADIATION, Lung cancer, 15(2), 1996, pp. 171-181
Authors:
ROED H
ENGELHOLM SA
SVENDSEN LB
ROSENDAL F
OLSEN KJ
Citation: H. Roed et al., PULSED DOSE-RATE (PDR) BRACHYTHERAPY OF ANAL CARCINOMA, Radiotherapy and oncology, 41(2), 1996, pp. 131-134
Authors:
MOLLER LA
ENGELHOLM SA
Citation: La. Moller et Sa. Engelholm, TREATMENT OF VAGINAL RECURRENCE IN ENDOMETRIAL CANCER - A REVIEW, Acta obstetricia et gynecologica Scandinavica, 75(1), 1996, pp. 1-7
Authors:
VINDELOV LL
CHRISTENSEN IJ
ENGELHOLM SA
GULDHAMMER BH
HOJGAARD K
SORENSEN BL
WOLF H
Citation: Ll. Vindelov et al., PROGNOSTIC-SIGNIFICANCE OF DNA CONTENT IN BLADDER-CANCER BASED ON FLOW CYTOMETRIC ANALYSIS OF 249 TRANSITIONAL-CELL CARCINOMAS, Cytometry, 22(2), 1995, pp. 93-102
Authors:
LARSEN LE
ENGELHOLM SA
Citation: Le. Larsen et Sa. Engelholm, THE VALUE OF 3-DIMENSIONAL RADIOTHERAPY PLANNING IN ADVANCED-CARCINOMA OF THE URINARY-BLADDER BASED ON COMPUTED-TOMOGRAPHY, Acta oncologica, 33(6), 1994, pp. 655-659
Authors:
PETERSEN LN
JENSEN PB
SORENSEN BS
ENGELHOLM SA
SPANGTHOMSEN M
Citation: Ln. Petersen et al., POSTINCUBATION WITH ACLARUBICIN REVERSES TOPOISOMERASE-II MEDIATED DNA CLEAVAGE, STRAND BREAKS, AND CYTOTOXICITY INDUCED BY VP-16, Investigational new drugs, 12(4), 1994, pp. 289-297
Authors:
FILTENBORG TA
HANSEN HH
ENGELHOLM SA
RORTH M
Citation: Ta. Filtenborg et al., A PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN AND CISPLATIN IN ADVANCEDAND RECURRENT SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX, Annals of oncology, 4(6), 1993, pp. 485-488
Authors:
STENBYGAARD LE
HERRSTEDT J
THOMSEN JF
SVENDSEN KR
ENGELHOLM SA
DOMBERNOWSKY P
Citation: Le. Stenbygaard et al., TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL, Breast cancer research and treatment, 25(1), 1993, pp. 57-63
Risultati:
1-13
|